Anna Masajtis‐Zagajewska

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3–5

Ilona Kurnatowska, Piotr Grzelak, Anna Masajtis‐Zagajewska et al. · Polskie Archiwum Medycyny Wewnętrznej · 2015 · 113 citations · Full text

Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease

Ilona Kurnatowska, Piotr Grzelak, Anna Masajtis‐Zagajewska et al. · Kidney & Blood Pressure Research · 2016 · 58 citations · Full text

Diagnosis and Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease – Position Statement of the Working Group of the Polish Society of Nephrology

Marcin Adamczak, Anna Masajtis‐Zagajewska, Oktawia Mazanowska et al. · Kidney & Blood Pressure Research · 2018 · 34 citations · Full text

Similar prevalence but different characteristics of pain in kidney transplant recipients and chronic hemodialysis patients

Anna Masajtis‐Zagajewska, Piotr Pietrasik, Joanna Krawczyk et al. · Clinical Transplantation · 2010 · 33 citations